The prognostic value of serum lactate dehydrogenase levels in patients with carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-negative colorectal cancer
Surgery Today · 2025
DOI: 10.1007/s00595-025-03209-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Yasuhiro Takano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi- shimbashi, Minato-ku, Tokyo, 105-8461, Japan. y.takano1864@jikei.ac.jp. Hauptthemen laut MEDLINE: Carcinoembryonic Antigen, Colorectal Neoplasms, CA-19-9 Antigen, Biomarkers, Tumor. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Lactate dehydrogenase (LDH) is an enzyme involved in the cellular energy metabolism of cancer cells. We conducted this study to evaluate serum LDH as a prognostic marker for predicting the outcomes of colorectal cancer (CRC) patients with negative carcinoembryonic antigen (CEA) and carbohydrate antigen 19 - 9 (CA19-9) levels. METHODS: The subjects of this retrospective study were 369 patients with stage II/III CRC and negative preoperative CEA and CA19-9 levels. Serum LDH levels were measured within 4 weeks before surgery and the association between serum LDH levels and survival outcomes was investigated. RESULTS: Fifty-five (15%) of the 369 patients had a high LDH of ≥ 212 U/L (high LDH group). Multivariate analysis identified that N stages 1‒3 (P = 0.019), serum LDH levels ≥ 212 U/L (P = 0.038), and a modified Glasgow Prognostic Score of 2 (P = 0.031) were independent predictors of disease-free survival (DFS). American Society of Anesthesiologists physical status ≥ 3 (P = 0.019), N stages 1‒3 (P = 0.009), and serum LDH levels ≥ 212 U/L (P < 0.001) were also independent predictors of overall survival (OS). CONCLUSION: The serum LDH level is a valuable prognostic marker for predicting the outcomes of CRC patients, even those with negative CEA and CA19-9 levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi- shimbashi, Minato-ku, Tokyo, 105-8461, Japan. y.takano1864@jikei.ac.jp.
- Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi- shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
- Department of Surgery, Tokyo General Hospital, 3-15-2, Ekoda, Nakano, Tokyo, 165-8906, Japan.
- Department of Digestive Surgery, Kawaguchi Municipal Medical Center, 180, Nishiaraijuku, Kawaguchi City, 333-0833, Saitama, Japan.
Zitieren
APA
Takano, Y., Kamada, T., Goto, K., Tsukihara, S., Kobayashi, Y., Imaizumi, Y., Ryu, S., Takeda, Y., Ohkuma, M., Kosuge, M., & Eto, K. (2025). The prognostic value of serum lactate dehydrogenase levels in patients with carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-negative colorectal cancer. Surgery Today. https://doi.org/10.1007/s00595-025-03209-5
Vancouver
Takano Y, Kamada T, Goto K, Tsukihara S, Kobayashi Y, Imaizumi Y, et al. The prognostic value of serum lactate dehydrogenase levels in patients with carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-negative colorectal cancer. Surgery Today. 2025. doi:10.1007/s00595-025-03209-5
BibTeX
@article{Takano2025,
author = {Takano, Yasuhiro and Kamada, Teppei and Goto, Keisuke and Tsukihara, Shu and Kobayashi, Yasunobu and Imaizumi, Yuta and Ryu, Shunjin and Takeda, Yasuhiro and Ohkuma, Masahisa and Kosuge, Makoto and Eto, Ken},
title = {The prognostic value of serum lactate dehydrogenase levels in patients with carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-negative colorectal cancer},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03209-5}
}
EUVIMED